产品详情 |
Edit |   |
Product Name | Recombinant Human Active MAP3K8/Tpl2/COT Protein, CF |
Description | Purity >70%, by SDS-PAGE under reducing conditions and visualized by Colloidal Coomassie® Blue stain at 5 µg per lane. MW (observed): 70 kDa. The Recombinant Human Active MAP3K8/Tpl2/COT Protein from R&D Systems is derived from Sf 9 (baculovirus). The Recombinant Human Active MAP3K8/Tpl2/COT Protein has been validated for the following applications: Bioactivity. |
Size | 10 ug |
Concentration | n/a |
Applications | Bioactivity |
Other Names | Cancer Osaka thyroid oncogene, c-COT, COT, cot (cancer Osaka thyroid) oncogene, COTMEKK8, EC 2.7.11.25, EST, ESTF, ESTFLJ10486, Ewing sarcoma transformant, MAP3K8, mitogen-activated protein kinase kinase kinase 8, Proto-oncogene c-Cot, proto-oncogene serine/threoine protein kinase, Serine/threonine-protein kinase cot, Tpl-2, TPL2, Tumor progression locus 2, tumor progression locus-2 |
Gene, Accession, CAS # | MAP3K8, Gene ID: 1326, Accession: NM_005204 |
Catalog # | 4586-KS-010 |
Price | |
Order / More Info | Recombinant Human Active MAP3K8/Tpl2/COT Protein, CF from R&D SYSTEMS, INC. |
Product Specific References | n/a |
产品资料 |
|
|